MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 177 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2015. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $58,704,000 | +5.8% | 3,316,619 | +15.3% | 0.01% | 0.0% |
Q3 2016 | $55,464,000 | +6.4% | 2,875,278 | +7.6% | 0.01% | -8.3% |
Q2 2016 | $52,125,000 | -2.8% | 2,673,093 | +2.7% | 0.01% | 0.0% |
Q1 2016 | $53,627,000 | -0.1% | 2,601,967 | -0.5% | 0.01% | 0.0% |
Q4 2015 | $53,677,000 | +27.0% | 2,615,818 | +5.8% | 0.01% | +9.1% |
Q3 2015 | $42,263,000 | -5.9% | 2,471,535 | +2.6% | 0.01% | 0.0% |
Q2 2015 | $44,890,000 | -3.7% | 2,408,260 | -1.4% | 0.01% | 0.0% |
Q1 2015 | $46,606,000 | +22.6% | 2,442,656 | +5.7% | 0.01% | +22.2% |
Q4 2014 | $38,021,000 | +3.4% | 2,309,928 | +11.1% | 0.01% | -10.0% |
Q3 2014 | $36,767,000 | -15.6% | 2,078,386 | -1.5% | 0.01% | -16.7% |
Q2 2014 | $43,559,000 | -12.0% | 2,110,406 | -7.1% | 0.01% | -20.0% |
Q1 2014 | $49,525,000 | -16.8% | 2,272,834 | +1.3% | 0.02% | -16.7% |
Q4 2013 | $59,506,000 | +14.5% | 2,242,982 | +2.0% | 0.02% | 0.0% |
Q3 2013 | $51,982,000 | +22.3% | 2,199,720 | +11.3% | 0.02% | +12.5% |
Q2 2013 | $42,508,000 | – | 1,977,132 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |